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Exercise is a mainstay recommendation for fending off obesity
and preventing diabetes, cardiovascular problems, or simply to
release stress. Although physicians are certain about the many
health benefits of exercise, especially for obese patients, a satisfying
explanation for why exercise leads to long-term improvements in
health profiles isn’t nearly as clear. More obviously, exercise can
tip the positive imbalance between energy acquisition and energy
expenditure (Figure 1) [1–5] that can eventually result in obesity.
In Western countries, levels of obesity and its related metabolic
disorders are increasing at a rate that is considered of epidemic
proportions. Although the increasing prevalence of obesity is
anticipated by a combination of genetic predisposition and social
and environmental factors, working out the precise contributions is
fundamental to understanding the basic molecular mechanisms
controlling energy balance.
At a biochemical and physiological level, there is a considerable
amount of cross-regulation and integration between the mecha-
nisms controlling food intake, energy expenditure, and fat
deposition. Interestingly, increased fat deposition and excessive
body weight are associated with allostatic changes aiming to
restore energy balance. For instance, increased fat mass is
associated with increased production of leptin and other
adipose-derived hormones directed to reduce food intake and
promote energy expenditure. Conversely, states of reduced food
intake, such as fasting, induce an allostatic response directed to
save energy stores and increase the drive for food intake. However,
despite these allostatic responses to maintain energy balance,
under conditions of chronic hypercaloric excess (e.g., overnutri-
tion) and/or impedance (e.g., reduced physical exercise) the
efficiency and accuracy of these regulatory mechanisms are
defective. It has been suggested that toxic effects of lipid
accumulation in peripheral tissues, such as pancreatic b cells,
liver, heart, and skeletal muscle may be an underlying cause,
though the exact mechanism is unclear. This process is known as
lipotoxicity, and it has been linked with the pathophysiology of
insulin resistance, type 2 diabetes, liver disease, atherosclerosis,
and cardiovascular disease [6–9]. Interestingly, one of the
proposed anti-lipotoxic strategies is the promotion of fat oxidation
through exercise [5].
Food intake and energy expenditure are precisely modulated by
specific sets of neurons placed in an area of the brain called the
hypothalamus, which comprises the major portion of the ventral
part of the diencephalon. The hypothalamus is organized in
anatomically-defined neuronal clusters, called nuclei, forming
interconnected neuronal circuits via axonal projections. The
hypothalamus receives multiple inputs of information as diverse
as the sensory experience of eating, the process of ingestion,
absorption, metabolism and levels of energy storage. Thus,
hypothalamic neurons respond to peripheral nutrients, such as
glucose and fatty acids, and hormones, such as leptin, ghrelin and
insulin, by modifying the synthesis of orexigenic (feeding-promot-
ers) or anorexigenic (feeding-inhibitors) neuropeptides and then
adjusting feeding to the body’s nutritional energy demands. When
energy intake surpasses expenditure, the expression of orexigenic
neuropeptides (such as agouti-related protein (AgRP), and
neuropeptide Y (NPY)) diminishes and the expression of anorex-
igenic neuropeptides (such as cocaine and amphetamine-regulated
transcript (CART) and proopiomelanocortin (POMC)) increases.
Reverse changes occur when energy expenditure exceeds intake.
The impairment of this precise homeostatic system elicits
hyperphagia, obesity, and type 2 diabetes [10,11].
Atypicalproblemassociatedwithfailureofthecentralmechanism
governing energy balance is the development of resistance to
peripheral signals, such as insulin and leptin [12–15]. Although it is
well known that some of the molecular mechanisms leading to
insulin and leptin resistance involve alterations in key molecules of
their intracellular signaling pathways, such as signal transducer and
activatoroftranscription3(STAT3),suppressorofcytokinesignaling
3(SOCS3)andproteintyrosinephosphatase1B(PTP1B)[12,14,15],
why and how central insulin and leptin resistance are induced by
overnutrition is not completely understood. Current evidence has
demonstrated that one of the pathological mechanisms of leptin
resistance isderivedfromimpairmentofendoplasmicreticulum(ER)
function, a process known as ER stress and the associate unfolded
protein response (UPR) (Figure 2).
The ER is a sophisticated luminal network in which protein
synthesis, maturation, folding, and transport take place [16–18].
The term ER stress refers to the alterations of the protein folding
functionality of the ER, which leads to activation of a complex
signaling network termed the UPR that results in a coordinated
transcriptional response associated to attenuation of protein
synthesis, upregulation of ER folding machinery (a type of proteins
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proteins(Figure 2). If this UPR adaptive response is not sufficient to
resolve the protein-folding defect, ER impairment can lead to cell
dysfunction and, ultimately, to apoptotic cell death [18]. Previous
studies have demonstrated that ER stress and activation of UPR
pathways play a major role promoting obesity-induced insulin
resistance and type 2 diabetes in peripheral tissues. For example,
inflammation, free fatty acids (FFAs), and hyperglycemia in pancreatic
b cells elicit activation of the UPR, leading to decreased insulin mRNA
expression and inhibition in the insulin signaling [19–22]. Data
produced in the last two years have demonstrated that obesity and
overnutrition also induce hypothalamic ER stress [23–26]. Specifically,
overnutrition activates hypothalamic IKKb/NF-kB, a well-known
mediator of metabolic inflammation, which elicits ER stress (which also
promotes IKKb/NF-kB) and initiates UPR signaling pathways in the
hypothalamus, which in turn directs to inhibition of leptin receptor
signaling pathway (STAT3, SOCS3, and PTP1B) and insulin and
Figure 1. Altered energy balance leads to obesity and
metabolic disorders. (A) When the quantity of energy absorbed by
an animal (i.e., food intake) equals its energy expenditure (i.e., physical
activity/exercise), the result is a neutral energy balance that permits
body weight stability. In this situation lipids are stored in white adipose
tissue (WAT). (B) An imbalance in either food intake or energy
expenditure leads to increased body weight and obesity. In this
context, the storage capacity of WAT may become saturated, which
redirect lipids to be accumulated in peripheral organs such as liver,
muscle, and pancreas. In a first step, these lipids are accumulated as
triacylglycerols (TGs). When the storage capacity of these tissues is also
saturated, excess of lipids, enters in alternative non-oxidative pathways
that results in production of toxic reactive lipid species (such as
diacylglycerols and ceramides) leading to tissue-specific damage, a
process known as lipotoxicity.
doi:10.1371/journal.pbio.1000464.g001
Figure 2. ER stress and UPR signaling pathway. Under optimal
nutrient surplus of nutrients, the chaperone BiP remains associated to
the luminal surface of ER with three UPR transducer proteins (ER stress
sensors: IRE1, PERK, and ATF6), maintaining them inactive. Overnutrition
and lipid excess (as well as other insults, such as hypoxia, radiation,
oxidative stress, viral infections, etc.) lead to impairment of normal
protein folding in the ER, resulting in accumulation of unfolded proteins.
In this situation, BiP preferentially binds the misfolded proteins,
liberating the ER stress sensors. Dimerization and auto-phosphorylation
of IRE1 triggers its endoribonuclease activity to induce cleavage of XBP1
mRNA to its spliced form XBP1s, which upregulates genes encoding
chaperones and genes encoding for proteosome machinery, controlling
ER-associated degradation (ERAD). PERK is activated by homodimeriza-
tion and auto-phosphorylation leading to phosphorylation eIF2a, which
results in attenuation of general protein translation and increased
transcription of ATF4, which will induce transcription of pro-apoptotic
genes such as CHOP10. ATF6 released from BiP is translocated to Golgi
complex where it is cleaved by S1P/S2P proteases, releasing the 50 KDa
domain, that acts as a transcription factor of gene-encoding chaperones
including BiP. The overall effect of these events is an adaptive program
comprising four different sequential responses, depending on the grade
and persistence of the stimulated ER stress cell: (1) a transcriptional and
translational attenuation, which reduces synthesis of new proteins
preventing further accumulation of misfolded proteins; (2) upregulation
of genes encoding ER chaperones to increase protein folding in the ER
and prevent aggregation of unfolded proteins; (3) if stimuli persists,
proteosome machinery is increased by transcription induction of its
genes improving ERAD; and (4) if all of its processes do not rescue the
cell from the ER stress and if ER stress inducers persist, genes encoding
cell death and apoptosis of the cell will be induced. ATF4 and 6:
activating transcription factor 4 and 6; BiP: binding immunoglobulin
protein, also known as GRP78, glucose regulated protein 78 KDa;
CHOP10: C/EBP homologous protein, also known as DDIT3, DNA-
damage inducible transcript 3; eIF2a: eukaryotic initiation factor 2a
subunit; IRE1: inositol requiring enzyme 1; PERK: PKR-like ER kinase, also
known as dsRNA-dependent protein kinase like ER kinase; S1P/S2P: site-
1, site-2 proteases; XBP1: X-box binding protein 1; XBP1s: X-box binding
protein 1, spliced.
doi:10.1371/journal.pbio.1000464.g002
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that genetic inactivation of IKKb/NF-kB signaling, or pharmacolog-
ical interventions that improve protein folding (chemical chaperones),
recover leptin and insulin signaling and subsequently normalize food
intake and decrease body weight [23–26].
Exercise is believed to be a keystone of the treatment for obesity.
In fact, physical activity has long been reported to reduce body
weight and adiposity, increasing energy expenditure and improv-
ing the overall metabolic status of obese patients [5,27,28]. In
keeping with this evidence, current data have highlighted that
exercise improves hypothalamic insulin and leptin sensitivity in
rats [29,30], although the molecular underpinnings of this effect
remain unclear. In this issue of PLoS Biology, Jose ´ B.C. Carvalheira
and colleagues move our neurobiological understanding signifi-
cantly forward by suggesting a novel mechanism by which exercise
exerts its beneficial effects on energy balance through a hormonal
effect at the level of the hypothalamus [31]. They used two
different obese models, diet-induced obesity (DIO) rats and leptin-
deficient ob/ob mice, to show that exercise restores food intake,
insulin, and leptin sensitivity to the levels of lean (control) animals.
These effects are linked to: (1) normalized expression of
hypothalamic neuropeptides modulating feeding (such as NPY
and POMC) and (2) improvement of hypothalamic leptin and
insulin signaling pathways, all of them severely impaired in obese
animals. Of note, authors demonstrate that the molecular
mechanism under this action is the reduction of hypothalamic
IKKb/NF-kB activation and ER stress (both of them severely
increased in obese animals) through a novel hypothalamic
mechanism involving increased serum and hypothalamic expres-
sion of the pro-inflammatory cytokine interleukin-6 (IL-6), which
induces the expression of the anti-inflammatory cytokine interleu-
kin-10 (IL-10), also in the hypothalamus (Figure 3) [31].
The significance of these data is given by several novel findings.
First of all, although physical exercise was already a key strategy
for the prevention of obesity and related diseases [27,28], this
study provides new evidence showing how exercise exerts a direct
impact by improving the metabolic and cellular status of the
hypothalamus in the brain. Exercise reduces hypothalamic IKKb/
NF-kB and ER stress and improves insulin and leptin action in an
IL-6–dependent manner, which consequently decreases hyper-
phagia and body weight. Secondly, the effect of exercise seems to
be restricted to obese animals since, in absence of obesity, it does
not induce significant changes either in feeding or body weight or
biochemical and cellular parameters. Finally, in resting conditions
Figure 3. Exercise and ER stress in hypothalamus. Overnutrition increases hypothalamic activation of IKKb/NF-kB and ER stress (they enhance
each other), which leads to insulin and leptin resistance in the hypothalamus, hyperphagia, and obesity. Exercise reduces hypothalamic IKKb/NF-kB
activation and ER stress through a mechanism involving IL-6 and IL-10. As a result of this effect, insulin and leptin sensitivity, and consequently food
intake, are restored. Whether hypothalamic lipotoxicity contributes to increased activation of IKKb/NF-kB and ER stress will require further
investigation. 3V: third ventricle; ARC: arcuate nucleus of the hypothalamus; DMH: dorsomedial nucleus of the hypothalamus; IKKb/NF-kB: inhibitor of
nuclear factor kappa-B kinase subunit beta/nuclear transcription factor kappa-B; LHA: lateral hypothalamic area; PVH: paraventricular nucleus of the
hypothalamus; VMH: ventromedial nucleus of the hypothalamus.
doi:10.1371/journal.pbio.1000464.g003
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hyperphagic response, as well as the leptin and insulin resistance,
promoted by pharmacological administration of ER stress
inducers (such as the drug thapsigargin, which interferes with
Ca
+2 balance), in both normal and genetic models of cytokine
deficiency (such as toll-like receptor 4, Tlr4, deficient mice). These
data suggest that the IL-6-IL-10-IKKb/NF-kB axis is a potential
therapeutic target for the treatment of obesity [31]. In this sense,
recent evidence has shown that IL-6 treatment improves insulin
sensitivity [32] and that IL-6 is also released from the brain during
long-term exercise in humans [33]. Overall, these data reveal new
pathways and provide novel challenges for the understanding of
energy balance and the treatment of obesity., Bearing in mind that
lipotoxicity is one of the key mechanisms leading to ER stress in
peripheral tissues [6–9] and the main role of hypothalamic lipids
in the regulation of energy balance [9,34], it would be crucial to
assess whether alterations (genetic or diet-induced) of hypotha-
lamic lipid metabolism could lead to lipotoxicity and subsequently
to ER stress-induced obesity (Figure 3). Additionally, in order to
establish possible therapeutic targets, the effect of exercise on other
ER stress models should be examined. In their study, Carvalheira
and colleagues used thapsigargin as ER stress inducer [26,31];
alternative drugs, such as tunicamycin (which interferes with
protein glycosylation) and brefeldin A (which impairs ER-Golgi
vesicular transport) [23–25], or ideally genetic models will provide
new cues about the effect of exercise on hypothalamic ER stress.
In summary, the new study of Carvalheira and colleagues adds
further confirmation that hypothalamic ER stress is an important
pathogenic mechanism leading to obesity. It provides a novel
integrative framework to understand the deleterious metabolic
effects of overnutrition and, more importantly, provides a good
rationale for the indication of exercise to obese patients. Moreover,
it presents a ‘‘scientific evidence’’ to support the famous Latin
citation of the Roman poet Juvenal, ‘‘Mens sana in corpore sano,’’ and
that physical exercise is a key factor to maintain us and our brains
in a healthy state.
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